This paper is only available as a PDF. To read, Please Download here.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Canadian Journal of DiabetesAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article Info
Publication History
Accepted:
July 20,
2022
Received in revised form:
July 6,
2022
Received:
September 16,
2021
Publication stage
In Press Journal Pre-ProofFootnotes
KEY MESSAGES
What is known: Diabetes classification has traditionally considered type 1 and type 2 diabetes as two separate entities with different pathogenic mechanisms. Increasingly, there are more exceptions to this conventional paradigm, leading to a concept of mixed phenotypes in diabetes classification.
What is new: We report the case of an adolescent with unclear diabetes type that has been successfully treated with liraglutide therapy. Our case highlights the difficulty of diabetes classification and subsequent need for personalized medicine with regards to diabetes management.
Identification
Copyright
© 2022 Canadian Diabetes Association.
